Delivery Order SPE2DR25D2205-SPE2DR26F1F89
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,814.80 to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 ml pens on November 3, 2025, with an ultimate completion date of November 4, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly used within military and veteran healthcare systems supported...
- The Defense Logistics Agency awarded a delivery order valued at $10,058.42 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 ml pens on October 22, 2025, with an ultimate completion date of October 23, 2025. This firm fixed-price, non-set-aside contract will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $1,166.88 to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pens on August 8, 2025, with completion scheduled for August 11, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly used in military and veteran healthcare systems supported by the Defense...
- The Defense Logistics Agency awarded a delivery order valued at $3,305.29 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens on August 29, 2025, with an ultimate completion date of September 2, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly procured by federal agencies to support military...
- The Defense Logistics Agency awarded a delivery order valued at $2,015.06 to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pens with a completion deadline of April 25, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly used in military and federal healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $5,790.66 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens on September 3, 2025, with completion scheduled for September 4, 2025. This firm fixed-price, competitively awarded delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Trulicity is a brand-name diabetes medication commonly used in federal medical supply chains,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,201.20 for Trulicity 0.75 mg/0.5 mL pens on August 25, 2025, with completion scheduled for August 26, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly used within military and federal healthcare systems. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $10,343.94 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 ml pens on August 1, 2025, with an ultimate completion date of August 4, 2025. This firm fixed price delivery order was competitively awarded without set-aside restrictions and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Trulicity is a brand-name diabetes medication widely used in federal healthcare systems, including...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Trulicity 3 mg/0.5 mL pens valued at $10,644.05 on September 2, 2025, with completion scheduled for September 3, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Trulicity is a brand-name diabetes medication commonly used within military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $6,691.77 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pens on August 5, 2025, with an ultimate completion date of August 6, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly used in military and veteran healthcare...
- SPE2DR25D2205Indefinite Delivery Contract
- SPE2DR25D2205-SPE2DR26F1F89Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,587.05 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens on November 5, 2025, with completion scheduled for November 6, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly used within military and veteran healthcare systems supported by the Defense Health Agency. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The parent IDC serves as a comprehensive pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs globally. AmerisourceBergen's demonstrated capability to fulfill federal medical procurement requirements through open competition, combined with its extensive portfolio spanning multiple therapeutic domains, positions it as a critical vendor within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 11/5/25 |